Intro

Exploring the effects of the Biosecure Act on the biotech sector, including the involvement of the House Select Committee on the Chinese Communist Party and the recent modifications to the Act in Washington, and the decision by House Rules to delay its incorporation in the Defense Authorization Bill, sparking debates on its impact on life sciences firms.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app